OXT and major depressive disorder: Beyond intranasal oxytocin administration studies or linking oxytocin signaling pathway genetics to smartphone-log-data, such research designs could be used to investigate the effect of other psychopharmaceuticals such as SSRIs or ketamine/esketamine, and the signaling systems they target, on symptoms associated with major depressive disorder.